Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Marina Talamonti

Showing results (1-10 of 93) with videos related to

Pageof 10
Sort By:
Journal of the European Academy of Dermatology and Venereology : JEADV|July 25, 2024
Ocular complications in patients with psoriasis: Is dry eye associated with psoriasis?Marina Talamonti, Marco Galluzzo
Expert Opinion on Biological Therapy|August 6, 2021
Safety of COVID-19 vaccines in patients with psoriasis undergoing therapy with anti-interleukin agentsMarina Talamonti, Marco Galluzzo
Annals of Translational Medicine|September 21, 2020
Importance of genotyping patients for HLA-C*06:02: it provides not only pharmacogenetics implication in response to biologics drugs but also drug survival and drug-related costs informationMarina Talamonti, Marco Galluzzo
Dermatology Reports|March 6, 2025
Efficacy of tildrakizumab 200 mg for treating difficult-to-treat patient populations with moderate-to-severe plaque psoriasisPaolo Dapavo, Matteo Megna, Marina Talamonti
Journal of the American Academy of Dermatology|January 19, 2016
HLA-C*06 and response to ustekinumab in Caucasian patients with psoriasis: Outcome and long-term follow-upMarina Talamonti, Marco Galluzzo, Sergio Chimenti, et al.
Molecular Diagnosis & Therapy|April 5, 2017
The Role of Pharmacogenetics in Chronic Plaque Psoriasis: Update of the LiteratureMarina Talamonti, Simone D'Adamio, Luca Bianchi, et al.
Expert Opinion on Biological Therapy|March 9, 2017
Tildrakizumab for treating psoriasisMarco Galluzzo, Simone D'adamio, Luca Bianchi, et al.
The Journal of Dermatological Treatment|June 24, 2008
Long-term efficacy of adalimumab in generalized pustular psoriasisArianna Zangrilli, Marina Papoutsaki, Marina Talamonti, et al.
The Journal of Dermatological Treatment|April 21, 2018
Psoriasis in pregnancy: case series and literature review of data concerning exposure during pregnancy to ustekinumabMarco Galluzzo, Simone D'Adamio, Luca Bianchi, et al.
Expert Opinion on Biological Therapy|June 9, 2020
Status of a real-life cohort of patients with moderate-to-severe plaque psoriasis treated with secukinumab and considerations on the use of biological agents in the Covid-19 eraMarco Galluzzo, Lorenzo Tofani, Luca Bianchi, et al.
Pageof 10

Showing results (1-10 of 93) with videos related to

Sort By:
Pageof 10
Journal of the European Academy of Dermatology and Venereology : JEADV|July 25, 2024
Ocular complications in patients with psoriasis: Is dry eye associated with psoriasis?Marina Talamonti, Marco Galluzzo
Expert Opinion on Biological Therapy|August 6, 2021
Safety of COVID-19 vaccines in patients with psoriasis undergoing therapy with anti-interleukin agentsMarina Talamonti, Marco Galluzzo
Annals of Translational Medicine|September 21, 2020
Importance of genotyping patients for HLA-C*06:02: it provides not only pharmacogenetics implication in response to biologics drugs but also drug survival and drug-related costs informationMarina Talamonti, Marco Galluzzo
Dermatology Reports|March 6, 2025
Efficacy of tildrakizumab 200 mg for treating difficult-to-treat patient populations with moderate-to-severe plaque psoriasisPaolo Dapavo, Matteo Megna, Marina Talamonti
Journal of the American Academy of Dermatology|January 19, 2016
HLA-C*06 and response to ustekinumab in Caucasian patients with psoriasis: Outcome and long-term follow-upMarina Talamonti, Marco Galluzzo, Sergio Chimenti, et al.
Molecular Diagnosis & Therapy|April 5, 2017
The Role of Pharmacogenetics in Chronic Plaque Psoriasis: Update of the LiteratureMarina Talamonti, Simone D'Adamio, Luca Bianchi, et al.
Expert Opinion on Biological Therapy|March 9, 2017
Tildrakizumab for treating psoriasisMarco Galluzzo, Simone D'adamio, Luca Bianchi, et al.
The Journal of Dermatological Treatment|June 24, 2008
Long-term efficacy of adalimumab in generalized pustular psoriasisArianna Zangrilli, Marina Papoutsaki, Marina Talamonti, et al.
The Journal of Dermatological Treatment|April 21, 2018
Psoriasis in pregnancy: case series and literature review of data concerning exposure during pregnancy to ustekinumabMarco Galluzzo, Simone D'Adamio, Luca Bianchi, et al.
Expert Opinion on Biological Therapy|June 9, 2020
Status of a real-life cohort of patients with moderate-to-severe plaque psoriasis treated with secukinumab and considerations on the use of biological agents in the Covid-19 eraMarco Galluzzo, Lorenzo Tofani, Luca Bianchi, et al.
Pageof 10